SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

TAGLIATI, Federico
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.351
EU - Europa 1.561
AS - Asia 896
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 2
Totale 8.817
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.344
CN - Cina 649
UA - Ucraina 409
DE - Germania 373
IT - Italia 254
TR - Turchia 230
GB - Regno Unito 183
SE - Svezia 114
FI - Finlandia 102
PL - Polonia 44
RU - Federazione Russa 33
BE - Belgio 25
FR - Francia 16
VN - Vietnam 7
CA - Canada 6
IN - India 4
IR - Iran 4
EU - Europa 3
BR - Brasile 2
CZ - Repubblica Ceca 2
IE - Irlanda 2
NL - Olanda 2
AU - Australia 1
CL - Cile 1
DK - Danimarca 1
EC - Ecuador 1
KZ - Kazakistan 1
MX - Messico 1
NZ - Nuova Zelanda 1
RO - Romania 1
SG - Singapore 1
Totale 8.817
Salva come PNG Salva come JPEG
Città #
Woodbridge 890
Ashburn 730
Fairfield 716
Chandler 565
Houston 509
Jacksonville 488
Ann Arbor 380
Seattle 290
Wilmington 266
Cambridge 215
Addison 150
Nanjing 136
Izmir 134
Beijing 125
Ferrara 114
Princeton 99
Boardman 82
Dearborn 67
Milan 65
Shanghai 59
San Diego 58
Shenyang 44
Warsaw 44
Bremen 40
Nanchang 36
New York 36
Changsha 31
Hebei 29
Tianjin 28
Jinan 25
Brussels 24
Mountain View 24
Washington 22
Jiaxing 21
Kunming 20
Tappahannock 19
Falls Church 15
Norwalk 13
Guangzhou 12
Redwood City 12
Auburn Hills 11
Leawood 11
Indiana 10
Ningbo 10
Hefei 9
Helsinki 8
Lanzhou 8
San Mateo 8
Bologna 7
Dong Ket 7
Orange 7
Verona 7
Los Angeles 6
Padova 6
Taizhou 6
Des Moines 5
Hangzhou 5
Monmouth Junction 5
Munich 5
Yellow Springs 5
Ardabil 4
Augusta 4
Turin 4
Zhengzhou 4
Chengdu 3
London 3
Montréal 3
Posina 3
Redmond 3
San Francisco 3
Appiano Gentile 2
Changchun 2
Dublin 2
Fuzhou 2
Haikou 2
Kilburn 2
Kingston 2
Lappeenranta 2
Mumbai 2
Naples 2
Poggio Renatico 2
Prescot 2
Rome 2
Sorga 2
Taiyuan 2
Walnut 2
Weihai 2
Xian 2
Acton 1
Almaty 1
Bangalore 1
Baotou 1
Brno 1
Caldonazzo 1
Castello Di Fiemme 1
Chicago 1
Chongqing 1
Dongguan 1
Ferrara di Monte Baldo 1
Formia 1
Totale 6.861
Salva come PNG Salva come JPEG
Nome #
SRC homology-2-containing protein tyrosine phosphatase-1 restrains cell proliferation in human medullary thyroid carcinoma 334
Effect of Everolimus on Cell Viability in Nonfunctioning Pituitary Adenomas 157
Magmas Overexpression Inhibits Staurosporine Induced Apoptosis in Rat Pituitary Adenoma Cell Lines 156
Igf-I influences everolimus activity in medullary thyroid carcinoma 155
Proposal for a novel management of indeterminate thyroid nodules on the basis of cytopathological subclasses 148
Role of Ultrasonographic/Clinical Profile, Cytology, and BRAF V600E Mutation Evaluation in Thyroid Nodule Screening for Malignancy: A Prospective Study 147
Cyclooxygenase-2 inhibitors reverse chemoresistance phenotype in medullary thyroid carcinoma by a permeability glycoprotein-mediated mechanism 141
Selective activation of somatostatin receptor subtypes differentially modulates secretion and viability in human medullary thyroid carcinoma primary cultures: potential clinical perspectives. 136
Chemical Composition of Essential Oils from Thymus vulgaris, Cymbopogon citratus, and Rosmarinus officinalis, and Their Effects on the HIV-1 Tat Protein Function 134
Relevance of BRAF(V600E) Mutation Testing Versus RAS Point Mutations and RET/PTC Rearrangements Evaluation in the Diagnosis of Thyroid Cancer 133
Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion. 132
Cyclooxygenase-2 inhibitors prevent the development of chemoresistance phenotype in a breast cancer cell line by inhibiting glycoprotein p-170 expression. 131
Inhibition of epithelial growth factor receptor can play an important role in reducing cell growth and survival in adrenocortical tumors 128
Everolimus as a new potential antiproliferative agent in aggressive human bronchial carcinoids 128
Protein Kinase C Delta restrains growth in ACTH-secreting pituitary adenoma cells 123
Involvement of PKCβ and PKCδ isoforms in TSH signaling pathway in thyroid cancer cell lines 121
mTOR, AKT, p70S6K and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids 120
Early onset acromegaly associated with a novel deletion in CDKN1B 5'UTR region 115
Proteasomes and RARS modulate AIMP1/EMAP II secretion in human cancer cell lines. 114
Functional characterization of a new deletion in CDKN1B 5'-UTR region 113
The expression of the truncated isoform of somatostatin receptor subtype 5 associates with aggressiveness in medullary thyroid carcinoma cells. 113
IGF-I Proliferative Effects Are Inhibited by Targeting PKC in Human Endocrine Tumor Cells 112
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression. 112
Magmas, a Gene Newly Identified as Overexpressed in Human and Mouse ACTH-Secreting Pituitary Adenomas, Protects Pituitary Cells from Apoptotic Stimuli 111
BRAF V600E mutation analysis increases diagnostic accuracy for papillary thyroid carcinoma in fine needle aspiration biopsies. 111
Somatostatin receptor subtype 1 selective activation reduces cell growth and calcitonin secretion in a human medullary thyroid carcinoma cell line. 109
Magmas, a Novel Over-Expressed Gene in Pituitary Rat Cell Lines and in Human Pituitary Adenomas: A New Pituitary Biomarker? 108
mTOR, p70S6K, AKT and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids 107
null 106
Therapeutic concentrations of mitotane (o,p'-DDD) inhibit thyrotroph cell viability and TSH expression and secretion in a mouse cell line model. 104
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression 104
miR-15a and miR-16-1 down-regulation in pituitary adenomas 104
Growth hormone excess promotes breast cancer chemoresistance 103
Growth Hormone Enhances Breast Cancer Chemoresistance by Inhibiting JNK-Mediated Apoptosis 102
Mitotane enhances doxorubicin cytotoxic activity by inhibiting P-gp in human adrenocortical carcinoma cells 102
Magmas, a novel over-expressed gene in Pituitary rat cell lines and in human pituitary adenomas: a new pituitary bio marker? 101
Utilization of luminescent technology to develop a kinase assay: Cdk4 as a model system 101
Identification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomas. 101
Somatostatin, but not somatostatin receptor subtypes 2 and 5 selective agonists, inhibits calcitonin secretion and gene expression in the human medullary thyroid carcinoma cell line, TT. 100
N-carbamidoyl-4-((3-ethyl-2,4,4-trimethylcyclohexyl)methyl)benzamide enhances staurosporine cytotoxic effects likely inhibiting the protective action of Magmas toward cell apoptosis 100
Growth Hormone differentially modulates chemoresistance in human endometrial adenocarcinoma cell lines 99
An in vivo OctreoScan-negative adrenal pheochromocytoma expresses somatostatin receptors and responds to somatostatin analogs treatment in vitro 98
Somatostatin receptor subtypes 2 and 5 differentially affect proliferation in vitro of the human medullary thyroid carcinoma cell line TT 97
BRAFV600E analysis on fine needle aspiration biopsy increases diagnostic accuracy for papillary thyroid cancer in clinically unsuspected nodules 97
Deletion of exons 1-3 of the MEN1 gene in a large Italian family causes the loss of menin expression 93
null 92
Mitotane reduces human and mouse ACTH-secreting pituitary cell viability and function. 91
Cabergoline reduces cell viability in non functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion 90
PKCδ plays an important in regulating human medullary thyroid carcinoma cell viability 89
Growth hormone induces chemoresistance in breast cancer cells 87
Somatostatin receptor subtype 1 selective activation in human growth hormone- and prolactin-secreting pituitary adenomas: effects on cell viability, growth hormone and prolactin secretion. 83
Effects of mTOR inhibitors in the control of non functioning pituitary adenomas cell growth 83
R171Q MEN1 polymorphism in patients presenting with hyperparathyroidism 83
SHP-1 restrains cell proliferation in human medullary thyroid carcinoma 82
Role of complex Cdk4/Cyclin D1 in somatostatin subtype 2 receptor-mediated inhibition of cell proliferation of a medullary thyroid carcinoma cell line in vitro 82
Dopamine receptor 2 activation reduces cells viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion 81
Selected terpenes from leaves of Ocimum basilicum L. induce hemoglobin accumulation in human K562 cells 81
Protein Kinase C: A Putative New Target for the Control of Human Medullary Thyroid Carcinoma Cell Proliferation in Vitro 79
Multiple somatostatin receptor subtypes activation reduces cell viability in non-functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion 79
Allelic discrimination in the diagnosis of somatic BRAF V600E mutation on fine-needle aspiration biopsies 79
Growth Hormone enhances breast cancer chemoresistance by protecting from apoptosis 76
Role of Piuitary Tumour Transforming Gene 1 in medullary thyroid carcinoma 75
GH enhances breast cancer chemoresistance by inhibiting JNK-mediated apoptosis 72
Everolimus reduces human ACTH secreting pituitary adenoma in vitro cell viability by inhibiting IGF-I down-stream signalling 71
Differential mTOR and PI3K Pathway Activation in Human Bronchial Carcinoids 71
A Novel PKC beta II Inhibitor Induces Antiproliferative Effects in Human Pancreatic Neuroendocrine Tumor Cells 70
Caffeic Acid Enhances the Anti-Leukemic Effect of Imatinib on Chronic Myeloid Leukemia Cells and Triggers Apoptosis in Cells Sensitive and Resistant to Imatinib 70
GH influences breast cancer chemoresistanec independently of cell cycle perturbations 69
Selective Cyclo-oxygenase 2 inhibitors revert chemoresistance In Medullary thyroid carcinoma by a mechanism mediated by P-gp and PGH2 67
Role of complex cyclin D1/Cdk4 in somatostatin subtype 2 receptor-mediated inhibition of cell proliferation of a medullary thyroid carcinoma cell line in vitro 66
Cyclo-oxygenase 2 modulates chemoresistance in breast cancer cells involving NF-kB. 66
Bronchial carcinoid response to mTOR inhibitors depends on mTOR expression levels 65
Everolimus reduces human ACTH-secreting pituitary adenoma in vitro cell viability 65
IGF-I proliferative effects are inhibited by targeting PKC in human neuroendocrine tumor cells 65
Thyroid Nodule Screening for Malignancy: A Prospective Study on Ultrasonographic/Clinical Profile, Cytology and BRAF V600E Mutation Evaluation 64
Targeting PKC in human pancreatic neuroendocrine tumor cells 64
Real-time PCR is useful to detect menin gene deletions 64
Somatostatin inhibits a medullary thyroid carcinoma cell line growth by activating SHP-1 62
GH protects breast cancer cells from chemotherapy by blocking cytotoxic-induced apoptosis in estrogen receptor negative breast cancer cells 62
miR-26a targets PRKCD in ACTH pituitary adenoma 60
Evidence for pituitary tumour transforming gene 1 (PTTG-1) expression and its possible oncogenic role in medullary thyroid carcinoma. 59
Evaluation of PKC isoforms expression in thyroid cells lines and effects of a PKC beta II selective inhibitor 57
SSTR subtypes expression pattern influences the antiproliferative effects of somatostatin and lanreotide on human medullary thyroid carinomas in vitro 56
Effects of pasireotide on bronchial carcinoids in primary culture 56
Somatostatin differentially influences proliferation and gene expression by modulating SHP-1 and cAMP pathways in a human medullary thyroid carcinoma cell line 55
miR-26a regulates cell cycle in ACTH-secreting pituitary adenomas through Protein Kinase C delta 53
PGH2 blocks the chemosensitizing effects of COX-2 inhibitors by a NF-KB mediated mechanism 52
PRKCD Is a Target of miR-26a in ACTH Pituitary Adenoma 51
Validation of a murine model to study deregulated pituitary microRNA 51
mTOR inhibition influences cell viability of human bronchial carcinoids in vitro 50
mTOR inhibition influences cell viability of medullary thyroid carcinoma primary cultures 47
null 44
null 40
null 37
miR-26a and cell cycle control in ACTH secreting pituitary adenoma 30
Cytotoxicity of Isoxazole Curcumin Analogs on Chronic Myeloid Leukemia-Derived K562 Cell Lines Sensitive and Resistant to Imatinib 22
Dopamine receptor subtype 2 and somatostatin receptor subtype 5 expression influences somatostatin analogs effects on human somatotroph pituitary adenomas in vitro 18
mTOR inhibition hampers cell viability in selected human medullary thyroid carcinoma primary cultures 17
miR-26a Plays an Important Role in Cell Cycle Regulation in ACTH-Secreting Pituitary Adenomas by Modulating Protein Kinase C  16
Targeting protein kinase C by Enzastaurin restrains proliferation and secretion in human pancreatic endocrine tumors 16
Totale 8.893
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.446
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.446
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019652 0 0 0 0 0 0 0 0 0 0 240 412
2019/20201.957 294 59 79 272 146 263 179 198 151 200 84 32
2020/20211.231 108 106 59 168 54 122 48 148 30 149 174 65
2021/20221.041 37 101 68 20 47 54 48 41 36 87 113 389
2022/20231.192 110 102 63 162 191 170 74 94 134 9 49 34
2023/2024773 60 66 28 19 59 105 23 373 19 13 8 0
Totale 8.928